Digital Realty Trust Inc. Stock Falls Wednesday, Underperforms Market

argenx SE

Change company Symbol lookup

Select an option...

ARGX argenx SE

ENZC Enzolytics Inc

GREE Greenidge Generation Holdings Inc

MLM Martin Marietta Materials Inc

ERESW East Resources Acquisition Equity Warrant Exp 1st July 2027 *W EXP 07/01/2027

NRAC Noble Rock Acquisition Corp

DCGO DocGo Inc

VELOW Velocity Acquisition Equity Warrant Exp 24 Feb 2028 *W EXP 02/24/2028

MRC MRC Global Inc

BAC Bank of America Corp

Health Care : Biotechnology | Mid Cap Growth
Based in Netherlands

Company profile

argenx SE, formerly arGEN X BV, is the Netherlands-based biopharmaceutical company. It creates and develops a pipeline of differentiated antibody therapeutics using its discovery platform, Simple Antibody, which exploits characteristics of the llama immune system. The Company develops a pipeline of antibody therapeutics focused on cancer and autoimmune indications. It includes: ARGX-110, an antibody for heme malignancies and solid tumors, which modulates functions of tumor such as cell proliferation and survival; ARGX-111, an antagonist of c-Met, a receptor tyrosine kinase involved in cell proliferation, angiogenesis and metastasis in multiple solid tumors; ARGX-112, an antigen which targets atopic dermatitis by neutralization of IL-20 and IL-22 (interleukin) mediated signaling through blockade of their common receptor, among others.

Digital Realty Trust Inc. Stock Falls Wednesday, Underperforms Market

4:49 pm ET January 5, 2022 (MarketWatch) Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Digital Realty Trust Inc. (DLR) slipped 3.67% to $162.88 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 1.94% to 4,700.58 and Dow Jones Industrial Average falling 1.07% to 36,407.11. This was the stock's third consecutive day of losses. Digital Realty Trust Inc. closed $15.34 short of its 52-week high ($178.22), which the company achieved on December 31st.

The stock underperformed when compared to some of its competitors Wednesday, as CyrusOne Inc. (CONE) fell 0.11% to $89.52. Trading volume (1.5 M) eclipsed its 50-day average volume of 1.2 M.

Data source: Dow Jones Market Data, FactSet. Data compiled Janurary 5, 2022.

-MarketWatch Automation

(END) Dow Jones Newswires

January 05, 2022 16:49 ET (21:49 GMT)